
Health Experts Caution: Weight-Loss Injections Linked to Sudden Vision Loss
The UK’s health authorities have revised the product information for semaglutide treatments, alerting users to a very rare potential side effect known as NAION. Semaglutide, a GLP-1RA medication, is designed to curb appetite and enhance insulin secretion. It is marketed…















